Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 1B1 HC Surgical > Key Indicators
1B1 HC Surgical
0.3400.0000.00%
YOY
Do not show
Hide blank lines
(FY)2022/05/31(Q4)2022/05/31(Q2)2021/11/30(FY)2021/05/31
Financial Ratios
Efficiency Ratios
Cash Conversion Cycle (D)
9.92% 44.3259 -- -- -- -- -44.50% 40.3242
Receivable Turnover (T)
-26.95% 15.1876 -- -- -- -- 57.58% 20.7904
Inventory Turnover (T)
-2.58% 7.5435 -- -- -- -- 56.27% 7.7434
Account Payable Turnover (T)
-13.26% 12.9926 -- -- -- -- 17.66% 14.9781
Fixed Assets Turnover (T)
-11.58% 4.4124 -- -- -- -- -16.65% 4.9905
Total Asset Rate (T)
-18.01% 0.5744 -- -- -- -- 19.42% 0.7005
ROE
-0.03% 61.270% -- -- -- -- 177.86% 61.286%
ROA
-20.91% 18.976% -- -- -- -- 71.56% 23.993%
ROIC
-4.90% 36.495% -- -- -- -- 103.11% 38.373%
FCF to Salese
-18.35% 35.793% -- -- -- -- 41.03% 43.835%
FCF to Net Income
-15.35% 108.339% -- -- -- -- -1.83% 127.988%
Profitability Ratios
Gross Margin
-0.59% 86.308% -- -- -- -- -1.82% 86.823%
EBIT Margin
-8.50% 41.039% -- -- -- -- 31.15% 44.850%
Net Margin
-3.54% 33.038% -- -- -- -- 43.66% 34.250%
EBITDA Margin
-4.81% 49.682% -- -- -- -- 23.77% 52.192%
Tax Rate
-11.51% 12.185% -- -- -- -- -6.58% 13.771%
Interest Coverage (T)
-11.60% 44.5225 -- -- -- -- 258.43% 50.3654
R & D Expense Ratio
-- 0.000% -- -- -- -- -- 0.000%
Sales Expense Ratio
-- 0.000% -- -- -- -- -- 0.000%
Administration Expense Rate
-- 0.000% -- -- -- -- -- 0.000%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-35.85% 36.746% -- 36.746% 63.64% 51.416% 36.17% 57.277%
Total Assets to Common Equity Ratio
-23.77% 281.455% -- 281.455% 106.54% 368.313% 97.72% 369.235%
Interest-Bearing Liabilities To Asset Ratio
-8.93% 20.194% -- 20.194% -5.77% 21.182% -12.76% 22.174%
Current Ratio
-36.48% 1.1921 -- 1.1921 -36.43% 1.1783 -8.13% 1.8768
Quick Ratio
-39.36% 1.079 -- 1.079 -36.71% 1.0996 -2.49% 1.7792
Growth Ratios
Growth Ratios
Revenue CAGR (3Y)
-86.74% 1.775% -- -- -- -- -35.78% 13.389%
Revenue CAGR (5Y)
-36.73% 15.304% -- -- -- -- 24.17% 24.190%
Net Income CAGR (3Y)
-118.53% -3.977% -- -- -- -- -52.29% 21.466%
Net Income CAGR (5Y)
55.92% 37.291% -- -- -- -- 474.65% 23.917%
Dividend CAGR (3Y)
126.15% 22.760% -- -- -- -- -13.03% 10.064%
Dividend  CAGR (5Y)
-- 15.501% -- -- -- -- -- --
FCF  CAGR (3Y)
-89.05% 2.233% -- -- -- -- -90.22% 20.397%
FCF  CAGR (5Y)
243.59% 108.126% -- -- -- -- 300.79% 31.469%
FCF CAGR (1Y)
-133.51% -32.493% -- -- -- -- 593.60% 96.980%
Currency Unit
SGDSGDSGDSGD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
HC Surgical Specialists Ltd is a medical services group. It is engaged in providing endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services. The company's only operating segment is the healthcare segment. Geographically, it operates only in Singapore. It generates revenue from the provision of medical services and Consultancy fee income. The company has its facilities center and clinics at various places in Singapore.
CEO: --
Market: --
Watchlist